Industry News

Company Awarded National Cancer Institute Contract

Published in AIDS Weekly, May 5th, 1997

U.S. Bioscience Inc., West Conshohocken, Pennsylvania, reported it has been awarded a contract by the U.S. National Cancer Institute (NCI) for shelf life studies of clinical drug formulations under development for the treatment of patients with cancer and AIDS.

The contract is for a three-year basic term with two one-year extension options, with total estimated revenues to the company of approximately $2 million. The results of the studies conducted by the company are used to provide NCI investigators with information regarding the proper storage and handling of various drug products under investigation and to support NCI's Investigational New Drug Applications filed...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1997-05-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry